The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.

IBCD 2020 will explore routes through the continually evolving scientific, methodological and regulatory environment for drug and biomarker development. The EORTC, NCI, EMA, and AACR will will work alongside FDA and PMDA specialists  to build upon recommendations and action points established upon at the IBCD 2018 edition.

Find out more at


Cancer Drug Development Forum asbl
Registered office: c/o BLSI, Clos Chapelle-aux-Champs 30, 1200 Woluwe Saint Lambert, Belgium
Register of legal entities: the French Speaking Enterprise Court in Brussels
Enterprise number: 738.523.752
Tel: +32 2 880 62 70